MedTrace Logo

Optical Coherence Tomography Assessment of Intimal Tissue and Malapposition

NCT01137019 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2014-08-05

No results posted yet for this study

Summary

The purpose of this study is to use a high-resolution intracoronary imaging modality, called optical coherence tomography (OCT) to examine two different types of coronary artery stents used to treat patients with coronary artery disease.

Conditions

Interventions

DEVICE

Biolimus-eluting stent

The biolimus-eluting coronary stent contains a stainless steel platform on which an abluminally coated polylactic acid (PLA) biodegradable polymer is placed that eludes biolimus-A9.

DEVICE

Everolimus-eluting coronary stent

The everolimus-eluting coronary stent is a cobalt chromium platform stent with a permanent fluorinated copolymer matrix that eludes everolimus

Sponsors & Collaborators

  • Biosensors International

    collaborator OTHER

  • Dr Peter Barlis

    lead OTHER

Principal Investigators

  • Peter Barlis, MBBS PhD FRACP · Northern Hospital, Department of Cardiology, Victoria, Australia

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-10-31
Primary Completion
2014-12-31
Completion
2014-12-31

Countries

  • Australia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01137019 on ClinicalTrials.gov